Ionis Pharmaceuticals (IONS) PT Raised to $82 at RBC Capital
Get Alerts IONS Hot Sheet
Price: $61.05 -2.21%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $82.00 (from $80.00) while maintaining a rating.
You May Also Be Interested In
- JPMorgan Reiterates Overweight Rating on Ionis Pharmaceuticals (IONS)
- Nomura/Instinet Upgrades Malayan Banking Bhd (MAY:MK) to Buy
- JG Summit (JGS:PM) (JGSHF) PT Lowered to PHP28.50 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share